2025
SJR Q2
JCR Q2 · 3,8
33 matched articles
SCIE
Journal detail
Pulmonary Pharmacology and Therapeutics
- Publisher
- Academic Press
- Country
- United States · Northern America
- Type
- journal
- ISSN
-
1094553915229629
Integrated evaluation
Scopus side is Scimago SJR; WoS side is Master Journal List + JCR/JIF. Sources are matched on ISSN. WoS / JCR metrics are available for 1997 and later years only.
WoS / JCR data covers 1997 onward.
Scopus
Scopus · Scimago
- SJR 0,819
- Quartile Q2
- H-Index 87
- Cites/doc 3,77
- Docs (3y) 123
- Cites (3y) 406
Clarivate
Web of Science · JCR · 2025
- JCR Q Q2
- JIF 3,8
- 5Y JIF 3,2
- JCI 0,87
WoS indexes
- SCIE
Subject classification
Categories (SJR)
- Biochemistry (medical) Q2
- Medicine (miscellaneous) Q2
- Pharmacology (medical) Q2
- Pulmonary and Respiratory Medicine Q2
Areas
- Medicine
WoS categories
- Pharmacology & Pharmacy | Respiratory System
Yearly quartile comparison
Scimago (SJR) for all years; Clarivate (JCR / JIF / JCI) from 1997 onward. Latest year stays open; older years start collapsed.
WoS / JCR data covers 1997 onward.
| Year | SJR Q | JCR Q (1997+) | SJR | JIF (1997+) | 5Y JIF (1997+) | JCI (1997+) | JCI Q (1997+) | H-Index |
|---|---|---|---|---|---|---|---|---|
| 2025 | Q2 | Q2 | 0,819 | 3,8 | 3,2 | 0,87 | Q2 | 87 |
| 2024 | Q2 | Q2 | 0,79 | 2,8 | 2,8 | 0,85 | Q2 | 84 |
| 2023 | Q2 | Q2 | 0,786 | 3,3 | 2,8 | 0,83 | Q2 | 84 |
| 2022 | Q2 | Q3 | 0,776 | 3,2 | 3,1 | 0,89 | Q2 | 84 |
| 2021 | Q2 | Q3 | 0,671 | 3,3 | 3,1 | 0,83 | Q2 | 84 |
| 2020 | Q1 | Q2 | 1,061 | 3,4 | 3,3 | 0,95 | Q1 | 84 |
| 2019 | Q2 | Q3 | 0,851 | 2,7 | 2,6 | 0,86 | Q2 | 84 |
| 2018 | — | Q2 | — | 2,7 | 2,7 | 0,87 | Q2 | — |
| 2017 | Q2 | Q3 | 0,86 | 2,4 | 2,5 | 0,83 | Q2 | 84 |
| 2016 | Q2 | Q2 | 0,816 | 2,5 | 2,4 | — | — | 84 |
| 2015 | Q1 | Q2 | 1,015 | 2,9 | 2,7 | — | — | 84 |
| 2014 | Q1 | Q2 | 1,108 | 2,9 | 2,7 | — | — | 84 |
| 2013 | Q1 | Q2 | 0,979 | 2,6 | 2,5 | — | — | 84 |
| 2012 | Q1 | Q2 | 1,052 | 2,5 | 2,3 | — | — | 84 |
| 2011 | Q1 | Q2 | 1,116 | 2,8 | 2,3 | — | — | 84 |
| 2010 | Q1 | Q3 | 0,889 | 2,1 | 2 | — | — | 84 |
| 2009 | — | Q3 | — | 2 | 2,1 | — | — | — |
| 2008 | — | Q2 | — | 2,3 | 2,2 | — | — | — |
| 2007 | — | Q2 | — | 2,6 | 2,3 | — | — | — |
| 2006 | — | Q2 | — | 2,8 | — | — | — | — |
| 2005 | — | Q3 | — | 1,6 | — | — | — | — |
| 2004 | — | Q2 | — | 2 | — | — | — | — |
| 2003 | — | Q2 | — | 1,9 | — | — | — | — |
| 2002 | — | Q2 | — | 2 | — | — | — | — |
| 2001 | — | Q2 | — | 1,5 | — | — | — | — |
| 2000 | — | Q3 | — | 1,1 | — | — | — | — |
| 1999 | — | Q4 | — | 0,6 | — | — | — | — |
| 1998 | — | Q3 | — | 0,9 | — | — | — | — |
JCR category quartile history
JCR / JCI quartile by year and category. 1997 and later.
WoS / JCR data covers 1997 onward.
| Year | Category | Edition | JCR Q (1997+) | JCI Q (1997+) | Rank |
|---|---|---|---|---|---|
| 2025 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 116/356 |
| 2025 | RESPIRATORY SYSTEM | SCIE | Q2 | Q2 | 28/107 |
| 2024 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 157/352 |
| 2024 | RESPIRATORY SYSTEM | SCIE | Q2 | Q2 | 44/108 |
| 2023 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 119/354 |
| 2023 | RESPIRATORY SYSTEM | SCIE | Q2 | Q2 | 32/101 |
| 2022 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 146/278 |
| 2022 | RESPIRATORY SYSTEM | SCIE | Q3 | Q2 | 36/66 |
| 2021 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 161/279 |
| 2021 | RESPIRATORY SYSTEM | SCIE | Q3 | Q2 | 39/66 |
| 2020 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 140/276 |
| 2020 | RESPIRATORY SYSTEM | SCIE | Q2 | Q1 | 28/64 |
| 2019 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 136/271 |
| 2019 | RESPIRATORY SYSTEM | SCIE | Q3 | Q2 | 33/64 |
| 2018 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | Q2 | 128/267 |
| 2018 | RESPIRATORY SYSTEM | SCIE | Q3 | Q2 | 32/63 |
| 2017 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | Q2 | 136/261 |
| 2017 | RESPIRATORY SYSTEM | SCIE | Q3 | Q2 | 35/60 |
| 2016 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 122/257 |
| 2016 | RESPIRATORY SYSTEM | SCIE | Q3 | — | 32/59 |
| 2015 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 79/255 |
| 2015 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 22/58 |
| 2014 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 87/255 |
| 2014 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 20/58 |
| 2013 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 108/256 |
| 2013 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 27/54 |
| 2012 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 109/261 |
| 2012 | RESPIRATORY SYSTEM | SCIE | Q3 | — | 26/50 |
| 2011 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 94/261 |
| 2011 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 17/48 |
| 2010 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 139/252 |
| 2010 | RESPIRATORY SYSTEM | SCIE | Q3 | — | 27/46 |
| 2009 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 138/237 |
| 2009 | RESPIRATORY SYSTEM | SCIE | Q3 | — | 25/43 |
| 2008 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 111/219 |
| 2008 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 17/40 |
| 2007 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 75/205 |
| 2007 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 12/34 |
| 2006 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 60/199 |
| 2006 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 11/34 |
| 2005 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 113/193 |
| 2005 | RESPIRATORY SYSTEM | SCIE | Q3 | — | 20/33 |
| 2004 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 82/187 |
| 2004 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 14/33 |
| 2003 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 82/185 |
| 2003 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 14/31 |
| 2002 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 66/188 |
| 2002 | RESPIRATORY SYSTEM | SCIE | Q2 | — | 15/32 |
| 2001 | PHARMACOLOGY & PHARMACY | SCIE | Q2 | — | 85/186 |
| 2001 | RESPIRATORY SYSTEM | SCIE | Q3 | — | 17/30 |
| 2000 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 108/181 |
| 2000 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 22/29 |
| 1999 | PHARMACOLOGY & PHARMACY | SCIE | Q4 | — | 136/175 |
| 1999 | RESPIRATORY SYSTEM | SCIE | Q4 | — | 24/30 |
| 1998 | PHARMACOLOGY & PHARMACY | SCIE | Q3 | — | 104/178 |
| 1998 | RESPIRATORY SYSTEM | SCIE | Q3 | — | 19/29 |